新闻中心

NEWS CENTER

Great news! Won the honorary of "Abide by contracts and keep promises" in Yichang City

2022-07-15

In July 2022, Yichang Sanxia Proudin Bio-Pharmaceutical Co., Ltd. was awarded the enterprise honorary of "Abide by contracts and keep promises" in the 13th (2020-2021) of Yichang market supervision administration.

Learn more

Summary of "Safety Production Month" Activities in 2022

2022-07-13

June this year is the 21st National "Safety Production Month". In order to thoroughly study and implement General Secretary Xi Jinping's important expositions on production safety, and solidly promote the three-year special rectification of production safety in the provinces, municipalities and districts

Learn more

Learn from advanced representatives and be ready to shoulder responsibilities

2022-07-07

On the afternoon of July 1, 2022, Branch Committee Yichang Sanxia Proudin Bio-Pharmaceutical Co., Ltd. of the Communist Party of China organized the company's party members and activists desiring to join the Communist Party of China to visit and study at the New Citizen Party Member and Mass Service Center in Yichang High-tech Zone.

Learn more

Drill: Forestalling fire disasters

2022-06-30

On June 22, 2022, we carried out an emergency evacuation and fire-fighting drill. 130 staffs including CEO Wang Menghua, cadres and workers from each department participated.

Learn more

A new invention patent "A Process Control Method for the Preparation of Lysine Acetate" attained by Proudin

2022-06-14

Recently, Yichang Sanxia Proudin Biopharmaceutical Co., Ltd. received the "Notice of Granting Invention Patent" from China National Intellectual Property Administration, that the invention application "A Process Control Method for the Preparation of Lysine Acetate" by our company was noticed for granted, after the registration procedures, we will receive the letter of patent.

Learn more

Congratulations for passing the carbocisteine API production resumption inspection

2022-06-09

On June 6, 2022, we successfully pass the resumption of production site inspection and sample inspection by Hubei Provincial Drug Administration. The carbocisteine API produced by our company has finished the record for resumption production, and can be sold in the market again.

Learn more